Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 521.08 USD | +1.30% |
|
+1.05% | -10.85% |
| Market Cap | 11.86B 10.41B 9.58B 8.93B 16.84B 1,128B 17.19B 115B 44.66B 553B 44.53B 43.57B 1,926B | P/E 2026 * |
-73.8x | P/E 2027 * | 52.1x |
|---|---|---|---|---|---|
| Enterprise Value | 11.33B 9.95B 9.16B 8.53B 16.09B 1,077B 16.42B 110B 42.67B 529B 42.54B 41.62B 1,840B | EV / Sales 2026 * |
7.58x | EV / Sales 2027 * | 4.88x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +1.40% | ||
| 1 week | +1.05% | ||
| Current month | -3.31% | ||
| 1 month | +14.64% | ||
| 3 months | -5.07% | ||
| 6 months | -12.58% | ||
| Current year | -10.85% |
| 1 week | 505.63 |  | 545.87 |
| 1 month | 445.2 | | 545.87 |
| Current year | 416.21 | | 598.79 |
| 1 year | 284.02 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 07/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 10/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 20/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Friedman
CHM | Chairman | 83 | 21/07/2016 |
Rebecca Taub
BRD | Director/Board Member | 73 | 30/06/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 10/08/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Free | Founder | 1,220 | 0.0053% | ||
| 06-16 | Free | Director | 1,085 | 0.0047% | ||
| 06-16 | Baker Bros. Advisors LP
| Free | Company | 4,880 | 0.0212% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | +1.05% | +72.97% | +129.94% | 11.86B | |
| +4.84% | +6.42% | +77.85% | +138.12% | 56.21B | |
| +0.55% | +8.49% | +77.09% | +100.93% | 55.38B | |
| +4.18% | +8.92% | -9.45% | -9.08% | 23.75B | |
| +3.15% | +6.23% | +12.97% | +434.84% | 23.19B | |
| +3.64% | +10.54% | +39.81% | -4.50% | 18.14B | |
| +4.11% | +8.72% | +44.37% | -27.84% | 16.84B | |
| +2.57% | +20.26% | +181.98% | +355.99% | 15.86B | |
| +3.63% | +5.40% | +26.65% | +193.28% | 13.56B | |
| +7.20% | +10.70% | +42.91% | - | 12.97B | |
| Average | +3.52% | +7.03% | +56.71% | +145.74% | 24.78B | |
| Weighted average by Cap. | +3.26% | +6.78% | +59.98% | +138.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 1.31B 1.21B 1.13B 2.12B 142B 2.17B 14.54B 5.63B 69.79B 5.61B 5.49B 243B | 2.21B 1.94B 1.78B 1.66B 3.13B 210B 3.2B 21.44B 8.31B 103B 8.28B 8.1B 358B |
| Net income | -201M -176M -162M -151M -285M -19.11B -291M -1.95B -757M -9.38B -755M -738M -32.65B | 308M 270M 249M 232M 437M 29.25B 446M 2.99B 1.16B 14.36B 1.16B 1.13B 49.97B |
| Net Debt | -529M -465M -428M -399M -752M -50.31B -767M -5.14B -1.99B -24.7B -1.99B -1.94B -85.95B | -1.09B -961M -885M -824M -1.55B -104B -1.59B -10.64B -4.12B -51.09B -4.11B -4.02B -178B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$519.40 | +0.97% | 44,142 |
| 01/07/26 | US$514.39 | -4.20% | 303,751 |
| 30/06/26 | US$536.95 | +1.83% | 393,459 |
| 29/06/26 | US$527.28 | +2.85% | 446,960 |
| 26/06/26 | US$512.65 | -0.22% | 2,500,271 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
